Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

NCT01327781 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

62

Enrollment

NIH

Sponsor class

Conditions

HER2/Neu Positive
Recurrent Breast Carcinoma
Stage IIIC Breast Cancer AJCC v7
Stage IV Breast Cancer AJCC v6 and v7

Interventions

DRUG: Endoxifen Hydrochloride
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)